Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of Kras gene mutation and copy number gain in non-small cell lung cancer.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer - 1 Jan 2011

Sasaki Hidefumi, Hikosaka Yu, Kawano Osamu, Moriyama Satoru, Yano Motoki, Fujii Yoshitaka

Abstract excerpt

INTRODUCTION: Recent studies for the characterization of the lung cancer genome have suggested that Kras gene was frequently amplified and correlated with activating mutations of Kras, which occur in approximately 5 to 10% of Japanese lung cancers. METHODS: We analyzed Kras mutation and Kras copy...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromosome Aberrations
Share to DNA, Neoplasm
Share to Gene Dosage

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to In Situ Hybridization, Fluorescence

Share to Lymphatic Metastasis

Share to Neoplasm Staging

Share to Proto-Oncogene Proteins p21(ras)

Share to ras Proteins

Source

Identifiers

PMID: 21150464
DOI: 10.1097/JTO.0b013e31820594f0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-21150464-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of Kras gene mutation and copy number gain in non-small cell lung cancer.PMID 21150464Read ↗

Epidermal growth factor receptor gene amplification in surgical resected Japanese lung cancer.Semantic proximity Read ↗

Frequency and clinicopathologic correlates of KRAS amplification in non-small cell lung carcinoma.Semantic proximity Read ↗

Prognostic implications of epidermal growth factor receptor and KRAS gene mutations and epidermal growth factor receptor gene copy numbers in patients with surgically resectable non-small cell lung cancer in Taiwan.Semantic proximity Read ↗

KRAS mutation is an important predictor of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer.Semantic proximity Read ↗

Oncogenic activating mutations are associated with local copy gain.Semantic proximity Read ↗

Relationship between epidermal growth factor receptor gene mutation and copy number in Chinese patients with non-small cell lung cancer.Semantic proximity Read ↗

Comprehensive analysis of epidermal growth factor receptor gene status in lung adenocarcinoma.Semantic proximity Read ↗

Evaluation of the epidermal growth factor receptor gene mutation and copy number in non-small cell lung cancer with gefitinib therapy.Semantic proximity Read ↗

High MET gene copy number leads to shorter survival in patients with non-small cell lung cancer.Semantic proximity Read ↗

ALK gene copy number gains in non-small-cell lung cancer: prognostic impact and clinico-pathological correlations.Semantic proximity Read ↗

Increased <i>MET</i> Gene Copy Number Negatively Affects Survival of Surgically Resected Non–Small-Cell Lung Cancer PatientsSemantic proximity Read ↗

[KRAS and epidermal growth factor receptor gene mutation in non-small cell lung cancer].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.